Press Conference from Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer

作者：Rosalyn Anne Juergens, John M. Wrangle, Frank P. Vendetti, Sara C. Murphy, Ming Zhao, Barbara Coleman, Rosa Sebree, Kristen P. Rodgers, Craig M. Hooker, Noreli C. Franco, Beverly Lee, Salina D. Tsai, Igor Espinoza Delgado, Michelle A. Rudek, Steven A. Belinsky, James Gordon Herman, Stephen B. Baylin, Malcolm V. Brock, Charles M. Rudin · 年份：2023 · DOI：10.1158/2159-8290.22529045 · 研究领域：Epigenetics and DNA Methylation、Histone Deacetylase Inhibitors Research

mp3 file (49.6MB). Patients with recurrent metastatic non-small cell lung cancer have a morbid prognosis, but a new epigenetic therapy may have potential for this population. Cancer Discovery Editors-in-Chief Jose Baselga, M.D., Ph.D. and Lewis C. Cantley, Ph.D. moderated a press conference about this research on Wednesday, Nov. 9, 2011.